Matches in Wikidata for { <http://www.wikidata.org/entity/Q107213927> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q107213927 description "clinical trial" @default.
- Q107213927 description "ensayo clínico" @default.
- Q107213927 description "ensayu clínicu" @default.
- Q107213927 description "klinisch onderzoek" @default.
- Q107213927 description "клінічне випробування" @default.
- Q107213927 description "临床试验" @default.
- Q107213927 name "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 name "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 type Item @default.
- Q107213927 label "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 label "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 prefLabel "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 prefLabel "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 P1050 Q107213927-2F3FA941-1E3A-4156-8FC5-19BBF6724598 @default.
- Q107213927 P1132 Q107213927-5BAB8680-F579-4F23-A06C-97CC0526CA12 @default.
- Q107213927 P1476 Q107213927-63FDCC96-B6F5-4EB6-BEFE-5FD0296144EB @default.
- Q107213927 P17 Q107213927-25776ED2-60E5-443E-8042-434966DE271A @default.
- Q107213927 P1813 Q107213927-D3DE5373-053D-4098-B936-20F08A81A62D @default.
- Q107213927 P2899 Q107213927-F10D00B5-F9CB-423B-83B3-72A0C681495E @default.
- Q107213927 P3098 Q107213927-B5D2BB80-842B-49E5-8BE1-D4B796F5D57F @default.
- Q107213927 P31 Q107213927-213F8058-4697-47EF-B135-2FCDC43BDE90 @default.
- Q107213927 P580 Q107213927-10BB22B5-5C62-4E86-88D7-BA349FBCAB46 @default.
- Q107213927 P582 Q107213927-4D58E270-3FB5-46E5-8F5E-B0EE85AF2D99 @default.
- Q107213927 P6153 Q107213927-FC7C9E64-9EE3-4DE6-8612-2670B1B3DFA4 @default.
- Q107213927 P8005 Q107213927-DA1DFC01-25DD-462D-887E-DA26E44D5023 @default.
- Q107213927 P8363 Q107213927-352DD585-0494-451C-8737-CF0185B35C2D @default.
- Q107213927 P921 Q107213927-2D5DBCFC-1FEB-43E5-A329-F0406F300BD5 @default.
- Q107213927 P1050 Q467635 @default.
- Q107213927 P1132 "+250" @default.
- Q107213927 P1476 "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use" @default.
- Q107213927 P17 Q142 @default.
- Q107213927 P1813 "CARMYN" @default.
- Q107213927 P2899 "+18" @default.
- Q107213927 P3098 "NCT04811508" @default.
- Q107213927 P31 Q30612 @default.
- Q107213927 P580 "2020-08-04T00:00:00Z" @default.
- Q107213927 P582 "2021-08-31T00:00:00Z" @default.
- Q107213927 P6153 Q2945711 @default.
- Q107213927 P8005 Q76649708 @default.
- Q107213927 P8363 Q818574 @default.
- Q107213927 P921 Q64064942 @default.